Merck Outlines Vioxx Defense
Merck Outlines Vioxx Defense At its annual meeting, Merck discussed its planned defense against the flood of lawsuits brought on by the withdrawal of Vioxx, an arthritis pill taken at one time or another by 20 million Americans.